Description
Stenabolic (SR 9009) is a PPAR alpha modifier drug still under development, with its creation credited to Professor Thomas Burris of the Scripps Research Institute, as of 2015. Remarkably, it is marketed as a SARM and research chemical, drawing comparisons to Cardarine (GW-501516) due to its agonistic impact on Rev-ErbA. According to an article in “National Medicine,” SR 9009 enhances exercise capacity in mice by increasing mitochondria in skeletal muscle, earning it the moniker “exercise in a bottle” on the internet.
As previously mentioned, Stenabolic possesses the ability to influence the activity of skeletal muscle mitochondria, essentially boosting metabolic activity. This attribute aligns it with the effects of DNP, yet SR 9009 is notably safer and doesn’t counteract endurance goals. Unlike DNP, SR 9009 can replicate actual aerobic exercise benefits without the need for physical conditioning, enhancing endurance rather than impeding it.
(SR 9009) interacts with a protein known as Rev-erbA. This interaction proves crucial, as Rev-erbA influences fat and sugar metabolism in the liver, the generation of fat cells, and the body’s inflammatory responses. Consequently, SR 9009’s interaction with Rev-erbA enhances the effectiveness of your existing exercise routine, making even sedentary periods less detrimental to your objectives. The primary goal is to utilize energy from food consumption rather than storing it as fat, a feat at which SR 9009 excels. Moreover, it aids in the breakdown of existing fat.
Results:
Stenabolic (SR 9009) contributes to leanness and extended cardio distances with reduced fatigue, ultimately increasing VO2 max and enhancing overall endurance.
Furthermore, SR 9009 exhibits potential benefits for non-athletes by addressing obesity, metabolic syndrome, and type 2 diabetes.
Mice Studies:
Studies involving mice with low muscle mass, a sluggish metabolic rate, and poor running capacity showcased significant improvements in muscle and metabolic rate upon SR 9009 administration, even without exercise. Once allowed to exercise, these mice demonstrated a 50% increase in running distance without heightened fatigue.
Side Effects:
SR 9009 does not function as a typical fat burner, thyroid accelerator, or appetite suppressant like clenbuterol, T3, or certain stimulants. Therefore, users won’t experience crashes or fatigue while using it. However, due to its novelty and limited human athlete usage, more information is awaited regarding potential undesired effects.
Dosages:
Stenabolic should be administered at 20-30 milligrams (mg) per day, with adjustments up or down by 10 mg based on user preference. The recommended cycle duration ranges from 6-8 weeks, and it is advisable to stack SR 9009 with Cardarine (GW-501516) for a dual endurance boost. Notably, SR 9009 requires more frequent dosing, ideally 3-4 times per day, due to its shorter half-life, although some users have reported success with 2-3 doses per day.
Visit 
There are no reviews yet.